PRLD
Prelude Therapeutics Inc
3.80$
-3.1%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
Prelude Therapeutics Inc (PRLD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -16 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -26 | -24 | -32 | -23 | -27 | -21 | -34 | -26 | -19 | 23 | -22 | -16 | -33 | |
| 0.3 | 0.3 | 0.4 | 0.5 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | 0.3 | 0.4 | 0.4 | 1.5 | |
| 6.7 | 5.9 | 5.5 | 6.1 | 5.9 | 3.8 | 3.8 | 3.8 | 2.4 | 1.8 | 2.0 | 2.0 | 8.3 | |
| -0.9 | 3.7 | -5.2 | 6.1 | -0.9 | 4.3 | -6.9 | 0.7 | -2.6 | 37 | -14 | -4.1 | 17 | |
| 0.6 | 1.1 | 0.3 | 0.4 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 15 | 7.7 | 31 | 26 | 11 | 22 | 62 | 12 | 40 | -60 | 8.5 | -66 | -77 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | – | 0.0 | – | – | – | – | |
| – | – | – | – | -0.1 | -0.2 | -0.2 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.1 | 25 | 0.0 | 0.1 | -0.1 | 0.0 | -0.2 | 0.0 | 0.0 | 25 | -0.3 | 86 | 110 | |
| -11 | 9.4 | -0.6 | 3.1 | -17 | 1.3 | 28 | -15 | 21 | -12 | -14 | 4.7 | -0.1 | |
| -26 | -25 | -32 | -23 | -27 | -21 | -34 | -26 | -19 | 23 | -22 | -16 | -33 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.